• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
2.051431
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
67.08
1468.65
EPS(TTM)
Face Value()
Div & Yield %
0.5
1
0
 

an& rathi share & stock brokers ltd
IDBI Bank Q3 total business grows 12% YoY
Jan 05,2026
On a sequential basis, the bank’s total business rose 2.41%.

The bank's total deposits stood at Rs 3,07,828 crore in Q3 FY26, recording a 9% YoY growth and a 1.42% quarter-on-quarter (QoQ) increase.

During the quarter, net advances stood at Rs 2,38,806 crore, registering a growth of 15% YoY and 3.72% QoQ. CASA deposits were at Rs 1,35,630 crore, up 4% YoY but down 2.44% QoQ.

IDBI Bank is engaged in the business of monetary intermediation of commercial banks, saving banks, postal savings banks, and discount houses.

The bank’s standalone net profit jumped 97.5% to Rs 3,627.36 crore on a 9.6% rise in total income to Rs 9,593.64 crore in Q2 FY26 over Q2 FY25.

The counter slipped 3.61% to Rs 110.70 on the BSE.